Director, Medical Managed Markets, HEOR, & RWE
Sumitomo Pharma America
Apex, North Carolina, United States
Health Outcomes Risk by Incremental Anticholinergic Burden in Overactive Bladder
Thursday, October 24, 2024
4:38 PM – 4:42 PM EDT
Disclosure(s): Sumitomo Pharma America: Employee (Ongoing)